Skip to main content
  • New forms of administration for RUCONEST® for HAE
  • Expansion of rhC1INH clinical development in pre-eclampsia, contrast induced nephropathy and other potential large indications
  • Clinical development of protein replacement products in Pompe and Fabry diseases 
Cookies: This website uses cookies Check the cookies page for more information Accept Decline